|
1
|
Trotter SC, Sroa N, Winkelmann RR, Olencki
T and Bechtel M: A global review of melanoma follow-up guidelines.
J Clin Aesthet Dermatol. 6:18–26. 2013.PubMed/NCBI
|
|
2
|
Rastrelli M, Tropea S, Rossi CR and
Alaibac M: Melanoma: Epidemiology, risk factors, pathogenesis,
diagnosis and classification. In Vivo. 28:1005–1011.
2014.PubMed/NCBI
|
|
3
|
Linos E, Swetter SM, Cockburn MG, Colditz
GA and Clarke CA: Increasing burden of melanoma in the United
States. J Invest Dermatol. 129:1666–1674. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gong H, Song L, Lin C, Liu A, Lin X, Wu J,
Li M and Li J: Downregulation of miR-138 sustains NF-kB activation
and promotes lipid raft formation in esophageal squamous cell
carcinoma. Clin Cancer Res. 19:1083–1093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang H, Tang Y, Guo W, Du Y, Wang Y, Li P,
Zang W, Yin X, Wang H, Chu H, et al: Up-regulation of microRNA-138
induce radiosensitization in lung cancer cells. Tumour Biol.
35:6557–6565. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qiu S, Huang D, Yin D, Li F, Li X, Kung HF
and Peng Y: Suppression of tumorigenicity by microRNA-138 through
inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma
multiforme. Biochim Biophys Acta. 1832:1697–1707. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen P, Zeng M, Zhao Y and Fang X:
Upregulation of limk1 caused by microRNA-138 loss aggravates the
metastasis of ovarian cancer by activation of limk1/cofilin
signaling. Oncol Rep. 32:2070–2076. 2014.PubMed/NCBI
|
|
11
|
Poliseno L, Haimovic A, Segura MF,
Hanniford D, Christos PJ, Darvishian F, Wang J, Shapiro RL, Pavlick
AC, Berman RS, et al: Histology-specific microRNA alterations in
melanoma. J Invest Dermatol. 132:1860–1868. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Masoud GN and Li W: HIF-1α pathway: Role,
regulation and intervention for cancer therapy. Acta Pharm Sin B.
5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu Y, Liu J and Huang H: Recent agents
targeting HIF-1α for cancer therapy. J Cell Biochem. 114:498–509.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cuninghame S, Jackson R and Zehbe I:
Hypoxia-inducible factor 1 and its role in viral carcinogenesis.
Virology. 456-457:370–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong ZZ, Yao M, Wang L, Wu W, Gu X and Yao
DF: Hypoxia-inducible factor-1alpha: Molecular-targeted therapy for
hepatocellular carcinoma. Mini Rev Med Chem. 13:1295–1304. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu CL, Huang Q, Liu CH, Lin XS and Xie F:
Prognostic value of HIF-1α expression in patients with gastric
cancer. Mol Biol Rep. 40:6055–6062. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Slominski A, Kim TK, Brożyna AA,
Janjetovic Z, Brooks DL, Schwab LP, Skobowiat C, Jóźwicki W and
Seagroves TN: The role of melanogenesis in regulation of melanoma
behavior: Melanogenesis leads to stimulation of HIF-1α expression
and HIF-dependent attendant pathways. Arch Biochem Biophys.
563:79–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song T, Zhang X, Wang C, Wu Y, Cai W, Gao
J and Hong B: MiR-138 suppresses expression of hypoxia-inducible
factor 1α (HIF-1α) in clear cell renal cell carcinoma 786-O cells.
Asian Pac J Cancer Prev. 12:1307–1311. 2011.PubMed/NCBI
|
|
20
|
Morton SU, Scherz PJ, Cordes KR, Ivey KN,
Stainier DY and Srivastava D: microRNA-138 modulates cardiac
patterning during embryonic development. Proc Natl Acad Sci USA.
105:17830–17835. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Siegel G, Obernosterer G, Fiore R, Oehmen
M, Bicker S, Christensen M, Khudayberdiev S, Leuschner PF, Busch
CJ, Kane C, et al: A functional screen implicates
microRNA-138-dependent regulation of the depalmitoylation enzyme
APT1 in dendritic spine morphogenesis. Nat Cell Biol. 11:705–716.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eskildsen T, Taipaleenmäki H, Stenvang J,
Abdallah BM, Ditzel N, Nossent AY, Bak M, Kauppinen S and Kassem M:
MicroRNA-138 regulates osteogenic differentiation of human stromal
(mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA.
108:6139–6144. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao S, Wang J, Xie J, Zhang T and Dong P:
Role of miR-138 in the regulation of larynx carcinoma cell
metastases. Tumour Biol. Oct 24–2015.(Epub ahead of print).
|
|
24
|
Li J, Wang Q, Wen R, Liang J, Zhong X,
Yang W, Su D and Tang J: MiR-138 inhibits cell proliferation and
reverses epithelial-mesenchymal transition in non-small cell lung
cancer cells by targeting GIT1 and SEMA4C. J Cell Mol Med.
19:2793–2805. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Jiang L, Wang A, Yu J, Shi F and
Zhou X: MicroRNA-138 suppresses invasion and promotes apoptosis in
head and neck squamous cell carcinoma cell lines. Cancer Lett.
286:217–222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang L, Liu X, Kolokythas A, Yu J, Wang
A, Heidbreder CE, Shi F and Zhou X: Downregulation of the Rho
GTPase signaling pathway is involved in the microRNA-138-mediated
inhibition of cell migration and invasion in tongue squamous cell
carcinoma. Int J Cancer. 127:505–512. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang L, Dai Y, Liu X, Wang C, Wang A,
Chen Z, Heidbreder CE, Kolokythas A and Zhou X: Identification and
experimental validation of G protein alpha inhibiting activity
polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous
cell carcinoma. Hum Genet. 129:189–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu X, Wang C, Chen Z, Jin Y, Wang Y,
Kolokythas A, Dai Y and Zhou X: MicroRNA-138 suppresses
epithelial-mesenchymal transition in squamous cell carcinoma cell
lines. Biochem J. 440:23–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Giatromanolaki A, Sivridis E, Kouskoukis
C, Gatter KC, Harris AL and Koukourakis MI: Hypoxia-inducible
factors 1alpha and 2alpha are related to vascular endothelial
growth factor expression and a poorer prognosis in nodular
malignant melanomas of the skin. Melanoma Res. 13:493–501. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yeh YM, Chuang CM, Chao KC and Wang LH:
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis
by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Elstrom RL, Bauer DE, Buzzai M, Karnauskas
R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM and
Thompson CB: Akt stimulates aerobic glycolysis in cancer cells.
Cancer Res. 64:3892–3899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dang CV: Links between metabolism and
cancer. Genes Dev. 26:877–890. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng SC, Quintin J, Cramer RA, Shepardson
KM, Saeed S, Kumar V, Giamarellos-Bourboulis EJ, Martens JH, Rao
NA, Aghajanirefah A, et al: mTOR- and HIF-1α-mediated aerobic
glycolysis as metabolic basis for trained immunity. Science.
345:12506842014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng Y, Chen G, Hong L, Zhou L, Hu M, Li
B, Huang J, Xia L and Li C: How does hypoxia inducible factor-1α
participate in enhancing the glycolysis activity in cervical
cancer? Ann Diagn Pathol. 17:305–311. 2013. View Article : Google Scholar : PubMed/NCBI
|
